You have read all your free articles, to continue reading subscribe to read the rest of this content.
Ultimovacs has received a Notice of Allowance from the United States Patent and Trademarks Office (USPTO) concerning its US patent application on the use of vaccine-checkpoint inhibitor combinations to treat cancer. Subject to grant formalities, it is expected that a patent will issue with a pateAlready a subscriber Login You…
Gedea Biotech has been granted a patent by the United States Patent and Trademark Office for the treatment of fungal infections by the company’s compound glucono-δ-lactone (GDL). The patent can be kept in force until 2037, states the company in a press release. “The US market for treatmenAlready a subscriber…
Xbrane Biopharma has been granted two new patents by the Swedish patent and Registration Office (PRV). The patents relate to novel methods of using signal peptides to enhance the production yield and thereby lowering the production cost of recombinant proteins expressed in E.coli. The patents areAlready a subscriber Login You…
Immunovia has strengthened its patent protection for pancreatic cancer biomarkers by obtaining a global license from the South Korean company JW BioScience’s IP portfolio. The license agreement gives Immunovia global commercial rights for two biomarkers for early detection of pancreatic cancer.Already a subscriber Login You have read all your free…
